CN102387793B - 包括银离子源和薄荷醇的抗菌组合物及其用途 - Google Patents

包括银离子源和薄荷醇的抗菌组合物及其用途 Download PDF

Info

Publication number
CN102387793B
CN102387793B CN201080016122.XA CN201080016122A CN102387793B CN 102387793 B CN102387793 B CN 102387793B CN 201080016122 A CN201080016122 A CN 201080016122A CN 102387793 B CN102387793 B CN 102387793B
Authority
CN
China
Prior art keywords
menthol
concentration
bactericidal composition
silver ion
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201080016122.XA
Other languages
English (en)
Chinese (zh)
Other versions
CN102387793A (zh
Inventor
诺阿·哈达尔
阿米海·弗里曼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ramot at Tel Aviv University Ltd
Original Assignee
Ramot at Tel Aviv University Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ramot at Tel Aviv University Ltd filed Critical Ramot at Tel Aviv University Ltd
Priority to CN201410433436.XA priority Critical patent/CN104274490B/zh
Publication of CN102387793A publication Critical patent/CN102387793A/zh
Application granted granted Critical
Publication of CN102387793B publication Critical patent/CN102387793B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/38—Silver; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN201080016122.XA 2009-02-11 2010-02-11 包括银离子源和薄荷醇的抗菌组合物及其用途 Active CN102387793B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410433436.XA CN104274490B (zh) 2009-02-11 2010-02-11 包括银离子源和薄荷醇的抗菌组合物及其用途

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15153909P 2009-02-11 2009-02-11
US61/151,539 2009-02-11
PCT/IL2010/000128 WO2010092578A1 (en) 2009-02-11 2010-02-11 Antiseptic compositions comprising silver ions and menthol and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN201410433436.XA Division CN104274490B (zh) 2009-02-11 2010-02-11 包括银离子源和薄荷醇的抗菌组合物及其用途

Publications (2)

Publication Number Publication Date
CN102387793A CN102387793A (zh) 2012-03-21
CN102387793B true CN102387793B (zh) 2014-10-01

Family

ID=42101536

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201080016122.XA Active CN102387793B (zh) 2009-02-11 2010-02-11 包括银离子源和薄荷醇的抗菌组合物及其用途
CN201410433436.XA Expired - Fee Related CN104274490B (zh) 2009-02-11 2010-02-11 包括银离子源和薄荷醇的抗菌组合物及其用途

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201410433436.XA Expired - Fee Related CN104274490B (zh) 2009-02-11 2010-02-11 包括银离子源和薄荷醇的抗菌组合物及其用途

Country Status (9)

Country Link
US (2) US8968793B2 (https=)
EP (2) EP3106157B1 (https=)
JP (1) JP5693470B2 (https=)
CN (2) CN102387793B (https=)
ES (2) ES2597955T3 (https=)
IL (2) IL214558A (https=)
PL (2) PL3106157T3 (https=)
RU (1) RU2553363C2 (https=)
WO (1) WO2010092578A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104274490A (zh) * 2009-02-11 2015-01-14 雷蒙特亚特特拉维夫大学有限公司 包括银离子源和薄荷醇的抗菌组合物及其用途

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2011247875B1 (en) * 2011-09-16 2012-08-09 Robert White Disinfectant Compositions and Uses Thereof
CN102861102A (zh) * 2012-09-21 2013-01-09 华绣科技有限公司 一种纳米银抑菌喷剂
US20170106020A1 (en) * 2015-10-19 2017-04-20 Stanley James Harless Anesthetic/analgesic composition
US20180325840A1 (en) * 2015-11-19 2018-11-15 National Defense Education And Research Foundation Compositions and methods for preventing or treating fatty pancreas or ameliorating pancreas diseases caused by fatty pancreas, diabetes mellitus or other related disorders
RU2630971C1 (ru) * 2016-07-21 2017-09-15 Владислав Евгеньевич Кудрявцев Антисептическое средство
CN106342803A (zh) * 2016-08-04 2017-01-25 陈广圣 一种抗菌剂
CN106109351B (zh) * 2016-08-23 2020-03-10 广州洁康医药科技有限公司 一种杀菌修护清洗剂、制备方法及其应用
JP6954602B2 (ja) * 2017-02-08 2021-10-27 大学共同利用機関法人自然科学研究機構 活性抑制剤および皮膚感覚過敏抑制剤
CN107496452A (zh) * 2017-09-27 2017-12-22 苏州汇涵医用科技发展有限公司 生物胶体分散剂及其制备方法
CN109501693A (zh) * 2018-10-27 2019-03-22 天津华翔汽车顶棚系统有限公司 抗菌汽车顶棚及其制备方法
CN109674743B (zh) * 2019-03-07 2020-06-26 牡丹江医学院 一种伤口护理凝胶及其制备方法
CN110742905A (zh) * 2019-12-04 2020-02-04 武汉维斯第医用科技股份有限公司 含银的伤口护理液及制备方法
CN111620794B (zh) * 2020-05-29 2021-08-10 北京化工大学 一种多巴胺衍生物抗菌剂及其制备方法与应用
US11937653B2 (en) 2020-07-09 2024-03-26 Vitiprints, LLC Smart mask
EP4185105A4 (en) * 2020-07-21 2024-05-01 Spectrum Brands, Inc. Compositions and methods for treating aquarium water
CN111956665A (zh) * 2020-08-19 2020-11-20 白燕波 一种电解银离子消毒剂及其制备方法
RU2762506C1 (ru) * 2021-01-20 2021-12-21 Общество С Ограниченной Ответственностью «Диамед-Фарма» Средство для аппликации полости рта и носа и способ его применения в составе комплексной терапии инфекционно-воспалительных заболеваний носовой и ротовой полости
CN116059271A (zh) * 2023-01-31 2023-05-05 青岛市第五人民医院 组合抗菌药物、其制备方法及应用其的皮肤敷料
WO2024253916A1 (en) * 2023-06-05 2024-12-12 Coltene/Whaledent, Inc. Dissolvable cleansing strips for cleaning, disinfecting, or sterilizing healthcare devices
US20260021031A1 (en) * 2024-07-19 2026-01-22 Moxikom, LLC Cleansing and treatment solution for humans

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1480045A (zh) * 2003-07-21 2004-03-10 艳 林 广谱抗杀菌纳米软膏剂
US20040166174A1 (en) * 2003-02-26 2004-08-26 Frank Steven R. Treatment of gastrointestinal infections
US20060263445A1 (en) * 2003-02-26 2006-11-23 Frank Steven R Enhancement of bacteriacidal activity of silver colloids

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5662913A (en) 1991-04-10 1997-09-02 Capelli; Christopher C. Antimicrobial compositions useful for medical applications
ZA939117B (en) 1992-12-04 1994-08-05 Susanna Elizabeth Chalmers Pharmaceutical product
US5562643A (en) 1992-12-28 1996-10-08 Johnson; James B. Device and treatment for treatment of skin
IL125237A0 (en) 1996-01-12 1999-03-12 Procter & Gamble Disinfecting compositions and processes for disinfecting surfaces
US6093414A (en) 1997-08-11 2000-07-25 Christopher C. Capelli Silver-based antimicrobial compositions
FR2792500B1 (fr) * 1999-04-23 2004-05-21 Internat Redox Dev Composition aqueuse, notamment sous forme de gel, a base de ho2f , acides et ions metalliques, procede de preparation notamment quand lesdits ions sont ag2+ et utilisation dans le domaine de la desinfection et/ou du traitement de surface
US6794343B2 (en) * 2000-02-17 2004-09-21 Leonard Paul Liquid foaming shaving compositions
US6551608B2 (en) 2000-03-06 2003-04-22 Porex Technologies Corporation Porous plastic media with antiviral or antimicrobial properties and processes for making the same
US20020041852A1 (en) * 2000-08-18 2002-04-11 Napolitano Neil J. Dental composition for hypersensitive teeth
US7402239B2 (en) * 2001-01-09 2008-07-22 Ionics Perpetual, Inc. Water purification apparatus and method of using the same
US7364565B2 (en) 2001-07-27 2008-04-29 Ramot At Tel Aviv University Ltd. Controlled enzymatic removal and retrieval of cells
GB0127786D0 (en) * 2001-11-20 2002-01-09 Univ Nottingham Impregnation of antimicrobial substances
WO2004045572A1 (en) 2002-11-21 2004-06-03 J.P.M.E.D. Ltd. Compositions for treating infected skin and mucous membrane comprising an anti-microbial agent and an essential oil
US7642400B2 (en) 2004-03-08 2010-01-05 Mayo Foundation For Medical Education And Research Protein kinase C iota
CN1676135A (zh) * 2004-03-30 2005-10-05 刘芳佑 生银在制备抗菌消炎与元素药物及消毒剂方面的用途
US7390774B2 (en) * 2004-04-08 2008-06-24 Rohm And Haas Company Antibacterial composition and methods of making and using the same
US9028852B2 (en) 2004-09-07 2015-05-12 3M Innovative Properties Company Cationic antiseptic compositions and methods of use
US20060147533A1 (en) * 2004-12-31 2006-07-06 Vijayashree Balasubramanian Antimicrobial biomaterial for blood bags
US7473675B2 (en) * 2005-02-25 2009-01-06 Solutions Biomed, Llc Disinfectant systems and methods comprising a peracid, alcohol, and transition metal
US7511007B2 (en) * 2005-02-25 2009-03-31 Solutions Biomed, Llc Aqueous sanitizers, disinfectants, and/or sterilants with low peroxygen content
KR100779911B1 (ko) * 2006-07-21 2007-11-29 (주)엔피씨 상자성 은 나노입자를 함유한 통증완화제 조성물
CN1958679A (zh) * 2005-11-04 2007-05-09 鸿富锦精密工业（深圳）有限公司 纳米涂料、其制备方法及使用方法
EP1839666A1 (de) * 2006-02-15 2007-10-03 Tihomir Lelas Bluthochdruck-Mittel enthaltend tribomechanisch aktivierte Zeolithen
US20090029340A1 (en) 2006-01-04 2009-01-29 Do-Coop Technologies Ltd. Cryoprotective Compositions and Methods of Using Same
US20070225301A1 (en) * 2006-02-13 2007-09-27 Astion Inflammation Aps Treatment of acne and other diseases
WO2007120616A2 (en) 2006-04-11 2007-10-25 Tyco Healthcare Group Lp Wound dressings with anti-microbial and zinc-containing agents
US20080020061A1 (en) * 2006-07-21 2008-01-24 Hassler Mark A Therapeutic cream
KR100827182B1 (ko) * 2006-12-08 2008-05-02 김기영 은입자를 필수성분으로 하는 구강세정용 액상치약 조성물및 그를 이용한 무스형 치약
CN102387793B (zh) * 2009-02-11 2014-10-01 雷蒙特亚特特拉维夫大学有限公司 包括银离子源和薄荷醇的抗菌组合物及其用途
FR2972500B1 (fr) 2011-03-10 2015-05-08 Valeo Systemes Thermiques Boitier d'admission comprenant un echangeur thermique

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040166174A1 (en) * 2003-02-26 2004-08-26 Frank Steven R. Treatment of gastrointestinal infections
US20060263445A1 (en) * 2003-02-26 2006-11-23 Frank Steven R Enhancement of bacteriacidal activity of silver colloids
CN1480045A (zh) * 2003-07-21 2004-03-10 艳 林 广谱抗杀菌纳米软膏剂

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104274490A (zh) * 2009-02-11 2015-01-14 雷蒙特亚特特拉维夫大学有限公司 包括银离子源和薄荷醇的抗菌组合物及其用途
CN104274490B (zh) * 2009-02-11 2017-11-10 雷蒙特亚特特拉维夫大学有限公司 包括银离子源和薄荷醇的抗菌组合物及其用途

Also Published As

Publication number Publication date
US8968793B2 (en) 2015-03-03
US8968794B2 (en) 2015-03-03
JP2012517420A (ja) 2012-08-02
IL214558A (en) 2016-06-30
RU2553363C2 (ru) 2015-06-10
CN104274490B (zh) 2017-11-10
PL3106157T3 (pl) 2021-05-17
EP2395985B1 (en) 2016-07-27
CN102387793A (zh) 2012-03-21
EP3106157B1 (en) 2020-11-04
ES2846854T3 (es) 2021-07-29
WO2010092578A1 (en) 2010-08-19
IL214558A0 (en) 2011-09-27
IL246008B (en) 2019-08-29
US20100203158A1 (en) 2010-08-12
CN104274490A (zh) 2015-01-14
EP2395985A1 (en) 2011-12-21
EP3106157A1 (en) 2016-12-21
RU2011137204A (ru) 2013-03-20
JP5693470B2 (ja) 2015-04-01
HK1203851A1 (en) 2015-11-06
PL2395985T3 (pl) 2017-01-31
IL246008A0 (en) 2016-07-31
US20110159062A1 (en) 2011-06-30
ES2597955T3 (es) 2017-01-24
HK1167821A1 (en) 2012-12-14

Similar Documents

Publication Publication Date Title
CN102387793B (zh) 包括银离子源和薄荷醇的抗菌组合物及其用途
EP2916820B1 (en) Delivery of biologically-active agents using volatile, hydrophobic solvents
Buyana et al. Alginate-pluronic topical gels loaded with thymol, norfloxacin and ZnO nanoparticles as potential wound dressings
US20110091572A1 (en) Acne treatment compositions comprising nanosilver and uses
US20080020025A1 (en) Composition for wound care and method of using same
KR20120022930A (ko) 은 설파디아진 및 키토산을 사용하여 제조한 약용 크림 및 이의 제조 방법
EP3164139B1 (en) Topical compositions and methods for treating wounds
US20250017904A1 (en) Antimicrobial compositions containing a synergistic combination of activated creatinine and an imidazole antifungal agent
US20250009787A1 (en) Nitric Oxide Containing Foam Formulation for Topical Medical Use
EP1635850B1 (en) Antimicrobial silver comprising silver
CN102365075A (zh) 医用抗菌乳膏和其制备方法
EP3210619A2 (en) Topical formulation for treating skin or mucosal infections, preparation method and uses thereof
EP3982909A1 (en) Compositions and methods for the antiseptic treatment of biofilms on mammalian tissue
Kumawat et al. Overview and summary of antimicrobial wound dressings and its biomedical applications
HK1167821B (en) Antiseptic compositions comprising silver ions and menthol and uses thereof
HK1203851B (en) Antiseptic compositions comprising silver ions and menthol and uses thereof
WO2007143586A2 (en) Composition for wound care and method of using same
JP6182294B2 (ja) 殺菌組成物及び医薬
CN102427801A (zh) 使用硫酸新霉素b乳膏和壳聚糖制备的药用乳膏以及其制备方法
Sethi A REVIEW ON MOLECULAR IODINE (I2) AND ITS TOPICAL APPLICATION ON SKIN AS AN ANTISEPTIC
WO2025243071A1 (en) A medicinal composition of povidone iodine and a biopolymer and a process of making it
HK1212231B (en) Delivery of biologically-active agents using volatile, hydrophobic solvents

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1167821

Country of ref document: HK

C14 Grant of patent or utility model
GR01 Patent grant
REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1167821

Country of ref document: HK